Ask AI
ProCE Banner Series

A Multidisciplinary Roadmap for Integrating Bispecific Antibodies to Enhance Outcomes in Follicular Lymphoma Care

Explore the evolving role of bispecific antibodies in follicular lymphoma through an expert-led, multidisciplinary workshop. Gain practical insights into mechanisms of action, administration strategies, and comparative advantages of bispecific over CAR T-cell therapy alongside real-world case discussions, guideline updates, and the latest clinical data on approved and emerging agents. Develop essential tools for integrating these novel therapies into practice to enhance patient outcomes and safety.

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This activity is intended for oncologists, hematologists, nurses, pharmacists, physician associates, advanced practice providers, and other healthcare professionals caring for patients with follicular lymphoma.

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to elevate learners' knowledge and competence in integrating bispecific antibodies to improve outcomes in patients with follicular lymphoma. 

Target Audience
This activity is intended for oncologists, hematologists, nurses, pharmacists, physician associates, advanced practice providers, and other healthcare professionals caring for patients with follicular lymphoma.

Learning Objectives
Upon completion of this event, participants should be able to:

  • Explain the mechanism of action of novel and investigational bispecific antibodies for treating follicular lymphoma.
  • Integrate clinical trial data, guideline recommendations, and patient-specific factors to aid in refining individualized treatment plans, including therapy sequencing, for the use of bispecific antibodies in patients with follicular lymphoma.
  • Manage TRAEs associated with bispecific antibodies, using best practices and patient counseling, to emphasize the importance of reporting and addressing toxicities to improve adherence to therapy, patient quality of life, and clinical outcomes.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: Specific to each event

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification 

A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC.

CCO 2022

Supporters

Supported by educational grants from Genentech, a member of the Roche Group and Regeneron Pharmaceuticals, Inc.

Genentech, a member of the Roche Group

Regeneron Pharmaceuticals, Inc.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191